A Phase I Clinical Trial to Evaluate the Safety of Different Immunization Schedules of a Lyophilized Human Rabies Vaccine (Human Diploid Cell)

NCT07338786 · clinicaltrials.gov ↗

PHASE1

Phase

ENROLLING_BY_INVITATION

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

RabiesPrevention

Interventions

DRUG: Lyophilized Human Rabies Vaccine (Human Diploid Cell)

Sponsor

Changchun BCHT Biotechnology Co.